This conference will take place in Kitty Hawk, NC, May 13 - 14. This course is designed to provide data-driven and practical recommendations to clinicians, patients and caregivers for coping with the challenges of cancer.
UNC biochemist Yi Zhang, PhD, whose team conducted the studies, called the findings an important step in understanding the molecular mechanisms behind cell differentiation and the development of cancer.
The study is sponsored by UNC Lineberger and financially supported by Bayer HealthCare AG, which will provide study medication free of charge to patients enrolled on the trial.
The grant will fund laboratory research to test whether a new class of drugs called PARP-inhibitors, which have successfully been used to treat other types of cancers, along with nanoparticle anti-cancer agents may be effective in treating brain metastases from triple-negative breast cancer.
The UNC Supportive Care and Consult Service and Clinic’s innovative model of a pharmacist as part of the care team in the outpatient setting continues to attract national attention and interest.
An uncommon tumor and two co-existing conditions it triggered have given a 55-year-old Lenior, N.C., man a roller-coaster of a medical journey. He’s also gained a precious gift: more time with his grandson.
The increasing incidence was most dramatic for white females ages 18 to 44. They had a percentage change of 111 percent. Interestingly, the incidence decreased for African American and other racial groups.
Federico Innocenti, MD, PhD, has been appointed associate professor of pharmacy in the UNC Eshelman School of Pharmacy. He will serve as associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy and a member of UNC Lineberger Comprehensive Cancer Center.
Interested in starting a regular exercise program and supporting a good cause? Nearly 1,000 women have improved their overall fitness during the 10-year Sole Sisters program and provided close to $50,000 for Susan G. Komen N.C. Triangle affiliate programs.
A new commentary by four internationally prominent genetic medicine and bioethics experts cautions against the dangers of inflated expectations for genomics research and offers ways to avoid it while still realizing “the true – and considerable – promise of the genomic revolution.”
60-year-old Maxine Pender of Edgecombe County receives healthy stem cells from her older brother for a bone marrow transplant, the tried and true treatment for her type of leukemia.
This center and its facility enables advanced research in cancer, neuroscience, medical imaging, computer science, drug discovery, nanotechnology, and imaging instrumentation.
Dr. Anders was chosen for her work on the identification of the prognosis and treatment of breast cancer brain metastases. Dr. Hoadley is being recognized for her contributions to a UNC-led analysis of glioblastomas (fast-growing malignant brain tumors).
It's a gene called DOT1L, and if you don’t have enough of the DOT1L enzyme, you could be at risk for some types of heart disease. These findings by UNC researchers appear in the journal Genes and Development.
The projects focus on areas of the state where cancers, and in particular breast, lung and colorectal cancers, are common and place a burden on the health of North Carolinians.
Serious illness most often brings devastating hardship, but it also has the potential to bring blessings with positive impact. Two couples from eastern North Carolina are living proof of how serious illness binds strangers in life-enriching ways.
A team of researchers led by Blossom Damania, PhD, has shown for the first time that the Kaposi sarcoma virus has a decoy protein that impedes a key molecule involved in the human immune response.
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.
The program will feature talks by physician/scientists and a patient’s parents on topics ranging from indoor tanning to clinical trials and from genetic testing to psychosocial support for melanoma patients.
The enzyme, known as Rad18, detects a protein called DNA polymerase eta (Pol eta) and accompanies it to the sites of sunlight-induced DNA damage, enabling accurate repair. When Pol eta is not present, alternative error-prone polymerases take its place – a process that leads to DNA mutations often found in cancer cells.